Altimmune Inc (ALT)

8.265 +0.08 (+1.04%) USD  |  NASDAQ  |  Dec 20, 16:00
8.30 +0.04 (+0.42%) After-Hours: 20:00
More

Altimmune Debt to Equity Ratio: 0.00 for Sept. 30, 2024

Debt to Equity Ratio Chart

View Debt to Equity Ratio for ALT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
NovaBay Pharmaceuticals Inc 0.0476
Palatin Technologies Inc --
iBio Inc --
Theriva Biologics Inc --
Oragenics Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 147.86M
Total Liabilities (Quarterly) 14.49M
Shareholders Equity (Quarterly) 133.38M
Current Ratio 16.87